Thoratec Corporation

Skip to content

Trials & Outcomes

Momentum llI Logo

HeartMate 3™ Clinical Trial

HeartMate III

The MOMENTUM 3 trial is a prospective, multi-center, unblended randomized study comparing the HeartMate 3 Left Ventricular Assist System (LVAS) to the HeartMate II LVAS in advanced stage heart failure patients.

HeartMate II Clinical Trial Results

As Thoratec's first-line intermediate-to-chronic left ventricular assist device, the HeartMate II is the most widely used, extensively studied LVAD in the world as Bridge-to-Transplantation and Destination Therapy (i.e. for patient ineligible for cardiac transplant) for advanced heart failure.

A clinical trial to assess the incidence of HeartMate II® pump thrombosis in the current era when recommended practice for clinical management are adopted and to identify the risk factors associated with pump thrombosis events.

Learn More

Text Size: A A A

See usage guidelines, research articles, and publications for Thoratec products.

Explore Resource Library